Here are six new spine and orthopedic biologics that have launched, earned FDA approval or received additional clearances, as reported by Becker’s in the first half of 2026.
Note: This list is not exhaustive.
- Ventris Medical received additional patent coverage for its Backpack system.
- Xtant Medical launched the Trivium Shaped bone graft, part of the Trivium bone graft portfolio.
- MTF Biologics and Kolosis BIO launched DBX Fiber, the latest addition to the DBX portfolio.
- Medtronic’s Infuse bone graft earned the FDA’s premarket approval for one- and two-level transforaminal lumbar interbody spinal fusions.
- Kolosis Bio and nonprofit MTF Biologics launched Summit Matrix, a synthetic bone graft for spine and orthopedic surgeries.
- Tetrous earned a U.S. patent related to its EnFix family of demineralized cortical bone fiber implants.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
